Egide (ALGID) H2 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 TU earnings summary
6 Jun, 2025Executive summary
2024 consolidated revenue declined 15.5% year-over-year to €31.07M, reversing the 8.7% growth seen in 2023.
Revenue decrease attributed to lower sales at Egide SA (-15.8%), Egide USA (-21.7%), and Santier (-5.1%).
Strategic investments and customer diversification continued, with positive momentum expected for 2025.
Financial highlights
First half 2024 revenue was €15.43M, rising slightly to €15.64M in the second half, but still below H2 2023 (€17.56M).
At constant exchange rates, 2024 revenue would have been €30.03M.
American subsidiaries contributed 52.6% of group sales in 2024.
Outlook and guidance
Single-digit revenue growth expected in 2025, driven by diversification and new applications in Defense and Aerospace.
Growth to be supported by modernization of industrial tools and expansion in thermal batteries and firing systems at Egide USA.
Latest events from Egide
- 2025 revenue rose 4% to €31.34m, driven by thermal imaging and European market gains.ALGID
H2 2025 TU26 Jan 2026 - EBITDA turned positive as revenue rose 1%, but net loss widened due to Santier’s downturn.ALGID
H1 202522 Oct 2025 - 2024 revenue dropped 15.5%, but single-digit growth is forecast for 2025.ALGID
H2 202410 Sep 2025 - Thermal imaging and European growth drove a return to revenue expansion in H1 2025.ALGID
H1 2025 TU30 Jul 2025 - H1 2024 sales dropped 19%, but a €1.8M capital increase aims to support future growth.ALGID
H1 202413 Jun 2025